RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

Mid-Cap Stocks Healthcare Stocks
$123.46
-2.97 (-2.35%)
As of May 9, 1:12 AM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 23 82%
Hold 5 18%
Sell 0 0%
Price Target
Analyst Price Target -49.7% upside
Low Target $40.44
Average Target $62.10
High Target $74.58
Current Price $123.46
Current
$123.46
Target
$62.10
$40.44 $62.10 avg $74.58
Scenario Analysis
Bear Case
$40.44
-67.2%
Low target
Base Case
$62.10
-49.7%
Avg target
Bull Case
$74.58
+-39.6%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$175.77
-29.8% from high
52-Week Low
$109.50
+12.7% from low
50-Day SMA
$157.63
-21.7% vs SMA
200-Day SMA
$139.06
-11.2% vs SMA
RSI (14)
28.0
Oversold
Target vs 52W High
$62.10
-64.7% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 35 89% $369.21 -20.6%
DHR
Danaher Corp
 Strong Buy 30 87% $158.11 -7.6%
WAT
Waters Corp
 Buy 28 57% $189.60 -46.6%
A
Agilent Technologies Inc
 Strong Buy 28 79% $64.69 -44.0%
IQV
Iqvia Holdings Inc
 Strong Buy 31 87% $82.96 -53.6%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -84.8%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -58.2%
ILMN
Illumina Inc
 Hold 28 54% $169.36 +19.4%